Corporate Member, Virogen Biotech
Time of publication:     Reading times:     Typeface:【LargeMiddleSmall



VIROGEN BIOTECHNOLOGY PTE. LTD. (hereinafter referred to as VIROGEN Biotech) is a clinical-stage biopharmaceutical company headquartered in Singapore. We possess an experienced management and operational team, as well as a top-tier professional R&D unit, with most members having previously served in internationally renowned pharmaceutical companies or research institutes. They bring deep scientific expertise and extensive practical experience in drug discovery, translational medicine, clinical research, and product development.


With a primary focus on innovating drug research and development, VIROGEN Biotech maximizes the advantages of its toxin protein technology platform to establish collaborative partnerships with leading research institutions globally. Through our strategic global presence, we aim to drive advancements in immunity-related drug development. Our objective is to develop original drugs that are rapid, safe, and highly specific, capable of effectively resetting the human cellular immune system, ultimately benefiting patients worldwide.



Virogen (Hongkong)Biopharmaceutical Co.,Limited

Virogen (Hongkong) Biopharmaceutical Co., Limited, as a key component of VIROGEN's global business strategy, intends to establish a clinical and translational medicine research center. By leveraging Hong Kong's strategic location and the policy support of the Hong Kong Special Administrative Region (HKSAR), which prioritizes life and health technology development, we aim to attract global talent and integrate clinical resources from Hong Kong and Southeast Asia. Together, we will conduct clinical studies on VG712's lymphodepletion prior to CAR-T cell infusion and immune tolerance induction after organ transplantation, aiming for significant breakthroughs in tumor treatment and organ transplantation.


 
Previous:Individual Member, Dr. Yue HUANG
Next:Corporate Member, VMS Group